Cladis Investment Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Hold |
1,558
| – | – | 0.18% | 115 |
|
|
2025
Q1 | $326K | Hold |
1,558
| – | – | 0.24% | 99 |
|
|
2024
Q4 | $277K | Sell |
1,558
-277
| -15% | -$49.2K | 0.2% | 103 |
|
|
2024
Q3 | $362K | Hold |
1,835
| – | – | 0.25% | 94 |
|
|
2024
Q2 | $315K | Hold |
1,835
| – | – | 0.23% | 103 |
|
|
2024
Q1 | $334K | Hold |
1,835
| – | – | 0.25% | 102 |
|
|
2023
Q4 | $284K | Hold |
1,835
| – | – | 0.22% | 105 |
|
|
2023
Q3 | $274K | Hold |
1,835
| – | – | 0.24% | 98 |
|
|
2023
Q2 | $247K | Hold |
1,835
| – | – | 0.21% | 111 |
|
|
2023
Q1 | $292K | Buy |
1,835
+130
| +8% | +$20.7K | 0.26% | 102 |
|
|
2022
Q4 | $276K | Hold |
1,705
| – | – | 0.27% | 104 |
|
|
2022
Q3 | $229K | Buy |
1,705
+230
| +16% | +$30.9K | 0.25% | 109 |
|
|
2022
Q2 | $226K | Buy |
1,475
+150
| +11% | +$23K | 0.23% | 115 |
|
|
2022
Q1 | $215K | Buy |
+1,325
| New | +$215K | 0.17% | 136 |
|